[1] Panea R I, Love C L, Shingleton J R, Reddy A, Bailey J A, Moormann A M, Otieno J A, Ong'Echa J M, Oduor C I, Schroeder K, Masalu N, Chao N J, Agajanian M, Major M B, Fedoriw Y, Richards K L, Rymkiewicz G, Miles R R, Alobeid B, Bhagat G, Flowers C R, Ondrejka S L, Hsi E D, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin Y Y, Zhuang Y, Luftig M A, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B C, Seshadri V, Kim S Y, Gascoyne R D, Levy S, Mukhopadhyay M, Dunson D B, Dave S S. The whole genome landscape of Burkitt lymphoma subtypes. Blood 2019;
[2] Chan A C, Vali B E. Mantle cell lymphoma with unusual Burkitt-like morphologic features. Blood 2019; 133: 2729.
[3] Teachey D T, Pui C H. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol 2019; 20: e142-e154.
[4] Moshref R H, Hrynchak M. Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient. Blood 2019; 133: 381.
[5] Potter N, Jones L, Blair H, Strehl S, Harrison C J, Greaves M, Kearney L, Russell L J. Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia. Leukemia 2019; 33: 893-904.
[6] Song J Y, Venkataraman G, Fedoriw Y, Herrera A F, Siddiqi T, Alikhan M B, Kim Y S, Murata-Collins J, Weisenburger D D, Liu X, Duffield A S. Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma 2016; 57: 866-71.
[7] Ma L, He S, Li F, Yang J, Chang Y, Zhao K, Liu N. Effect of remained stem height on yield, quality of Inula helenium I. and on soil water content. Saudi J Biol Sci 2018; 25: 1208-1211.
[8] Liu Y R, Cai Q Y, Gao Y G, Luan X, Guan Y Y, Lu Q, Sun P, Zhao M, Fang C. Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling. Phytother Res 2018; 32: 643-650.
[9] Ding Y, Wang H, Niu J, Luo M, Gou Y, Miao L, Zou Z, Cheng Y. Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells. Int J Mol Sci 2016; 17: 558.
[10] Zhang J, Li Y, Duan D, Yao J, Gao K, Fang J. Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells. Biochem Pharmacol 2016; 102: 34-44.
[11] Khan M, Yi F, Rasul A, Li T, Wang N, Gao H, Gao R, Ma T. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction. IUBMB Life 2012; 64: 783-94.
[12] Wang J, Zhang Y, Liu X, Wang J, Li B, Liu Y, Wang J. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3beta pathway. Int J Mol Med 2019; 44: 1026-1038.
[13] Cao P, Xia Y, He W, Zhang T, Hong L, Zheng P, Shen X, Liang G, Cui R, Zou P. Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS. Int J Biol Sci 2019; 15: 1676-1684.
[14] Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, Zhao C. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Mol Carcinog 2019; 58: 565-576.
[15] He W, Cao P, Xia Y, Hong L, Zhang T, Shen X, Zheng P, Shen H, Zhao Y, Zou P. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway. Free Radic Res 2019; 53: 104-114.
[16] He R, Shi X, Zhou M, Zhao Y, Pan S, Zhao C, Guo X, Wang M, Li X, Qin R. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB. Toxicol Appl Pharmacol 2018; 356: 159-171.
[17] Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, Zhao C. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. Mol Carcinog 2019; 58: 565-576.
[18] He R, Shi X, Zhou M, Zhao Y, Pan S, Zhao C, Guo X, Wang M, Li X, Qin R. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB. Toxicol Appl Pharmacol 2018; 356: 159-171.
[19] Zhang X, Zhang H M. Alantolactone induces gastric cancer BGC-823 cell apoptosis by regulating reactive oxygen species generation and the AKT signaling pathway. Oncol Lett 2019; 17: 4795-4802.
[20] Yin C, Dai X, Huang X, Zhu W, Chen X, Zhou Q, Wang C, Zhao C, Zou P, Liang G, Rajamanickam V, Wang O, Zhang X, Cui R. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model. J Cell Mol Med 2019; 23: 2194-2206.
[21] Maryam A, Mehmood T, Zhang H, Li Y, Khan M, Ma T. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Sci Rep 2017; 7: 6242.
[22] Thatcher N, Wagstaff J, Mene A, Smith D, Orton C, Craig P. Corynebacterium parvum followed by chemotherapy (actinomycin D and DTIC) compared with chemotherapy alone for metastatic malignant melanoma. Eur J Cancer Clin Oncol 1986; 22: 1009-14.
[23] D'Arcy M S. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 2019; 43: 582-592.
[24] Xie Z Z, Li M M, Deng P F, Wang S, Wang L, Lu X P, Hu L B, Chen Z, Jie H Y, Wang Y F, Liu X X, Liu Z. Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt/mTOR signaling pathway. Chem Biol Interact 2017; 264: 1-9.
[25] Liu W, Wang X, Sun J, Yang Y, Li W, Song J. Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis. Onco Targets Ther 2017; 10: 453-461.
[26] Liu W, Wang X, Sun J, Yang Y, Li W, Song J. Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis. Onco Targets Ther 2017; 10: 453-461.
[27] Qi P, He Z, Zhang L, Fan Y, Wang Z. Rottlerin-induced autophagy leads to apoptosis in bladder cancer cells. Oncol Lett 2016; 12: 4577-4583.
[28] Xie W Y, Zhou X D, Yang J, Chen L X, Ran D H. Inhibition of autophagy enhances heat-induced apoptosis in human non-small cell lung cancer cells through ER stress pathways. Arch Biochem Biophys 2016; 607: 55-66.
[29] Maejima Y, Kyoi S, Zhai P, Liu T, Li H, Ivessa A, Sciarretta S, Del R D, Zablocki D K, Hsu C P, Lim D S, Isobe M, Sadoshima J. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med 2013; 19: 1478-88.
[30] Pattingre S, Tassa A, Qu X, Garuti R, Liang X H, Mizushima N, Packer M, Schneider M D, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-39.
[31] Chen Y, Zhang W, Guo X, Ren J, Gao A. The crosstalk between autophagy and apoptosis was mediated by phosphorylation of Bcl-2 and beclin1 in benzene-induced hematotoxicity. Cell Death Dis 2019; 10: 772.